Darnisha Harrison is the founder and CEO of Ennaid Therapeutics and it has emerged that her company has just filed a patent for a possible corona virus patent…. Here is an excerpt from Black Business.

Darnisha Harrison, founder and CEO of Ennaid Therapeutics, says that scientists working for her company have found a drug that is showing promise in laboratories at blocking the continued spread of COVID-19. Based in Atlanta, Georgia, her company uses its artificial intelligence (AI)-based drug discovery platforms to develop anti-viral drugs.

Both BET News and WBRZ-TV, an ABC News affiliate in Baton Rouge, have confirmed that Harrison, who graduated from Louisiana State University, has already filed a patent after discovering a drug that shows strong scientific evidence of blocking two proteins that cause COVID-19 from invading healthy host cells and replicating.


Read the full story here.

Video screen shot from https://ennaidthera.com/our-company/ and corona virus image public domain from Centers for Disease Control and Prevention.


PUBLIC NOTE: The opinions expressed in this article are the author's own and do not reflect the view of the Urban Intellectuals, affiliates or partners.

DISCLOSURE: Links to external businesses and products may be partner or affiliate links and earn Urban Intellectuals a commission. We stand by all recommended products.